NIPP-1 is the RNA-binding subunit of a major species of protein phosphatase-1 in the nucleus. We have expressed nuclear inhibitor of protein phosphatase-1 (NIPP-1) in Sf 9 cells, using the baculovirus-expression system. The purified recombinant protein was a potent (K i ‫؍‬ 9.9 ؎ 0.3 pM) and specific inhibitor of protein phosphatase-1 and was stoichiometrically phosphorylated by protein kinases A and CK2. At physiological ionic strength, phosphorylation by these protein kinases drastically decreased the inhibitory potency of free NIPP-1. Phosphorylation of NIPP-1 in a heterodimeric complex with the catalytic subunit of protein phosphatase-1 resulted in an activation of the holoenzyme without a release of NIPP-1. Sequencing and phosphoamino acid analysis of tryptic phosphopeptides enabled us to identify Ser 178 and Ser 199 as the phosphorylation sites of protein kinase A, whereas Thr 161 and Ser 204 were phosphorylated by protein kinase CK2. These residues all conform to consensus recognition sites for phosphorylation by protein kinases A or CK2 and are clustered near a RVXF sequence that has been identified as a motif that interacts with the catalytic subunit of protein phosphatase-1.
Nearly all cellular processes are controlled by the reversible phosphorylation of key proteins, mostly on serine or threonine residues. Mammalian cells contain hundreds of independently regulated protein kinases and protein phosphatases that catalyze specific phosphorylation and dephosphorylation reactions, respectively (1) . One of the most abundant and conserved families of Ser/Thr-specific protein phosphatases are the type-1 enzymes (PP-1). 1 They consist of a common catalytic subunit (PP-1 C ) and one or two unique regulatory subunits that specify the activity, the substrate specificity, and the subcellular localization of the holoenzyme (2, 3) . PP-1 is particularly abundant in the nucleus where it is presumed to play a regulatory role in mRNA processing, in transcription, and in the progression of the cell cycle. Mammalian nuclei contain two major species of PP-1, which are heterodimers between PP-1 C and the inhibitory polypeptides NIPP-1 or R111 (4, 5) . In addition, sds22 has been identified as an inhibitory subunit of a minor species of PP-1 in rat liver nuclei (6) . The retinoblastoma protein (7) and the splicing factor PSF (8) have also been reported to interact with PP-1 C , but it remains to be established whether they are real subunits of PP-1.
NIPP-1 was originally isolated from bovine thymus nuclei as a mixture of two heat stable inhibitors of protein phosphatase-1 (9) . cDNA cloning and Western analysis later revealed that the purified inhibitors, termed NIPP-1a (18 kDa) and NIPP-1b (16 kDa), were proteolytically derived from a single polypeptide of 39 kDa that is not heat stable (4, 10) . Both the heat stable fragments and intact NIPP-1 were shown to be present in the nuclear particulate fraction as a complex with PP-1 C , previously designated PP-1N R41 (4) and now termed PP-1N NIPP-1 . The inhibition of PP-1 C by NIPP-1 was found to be mediated by the central third of the polypeptide (10) , which is also an excellent substrate for phosphorylation by protein kinase A (PKA) and protein kinase CK2. Phosphorylation of NIPP-1a and NIPP-1b by these protein kinases reduced their inhibitory potency and resulted in their dissociation from PP-1 C (11, 12) . Recently, NIPP-1 was also reported to display RNA binding properties in vitro (13) .
Thus far, it has not been possible to study the properties of intact NIPP-1. Indeed, the inhibitor is rapidly degraded during purification of PP-1N NIPP-1 from nuclear extracts (4) . Likewise, the expression of NIPP-1 in bacteria has been hampered by rapid intrabacterial proteolysis (10) . Neither has it been possible to overexpress NIPP-1 protein in mammalian cells, due to a translational control mechanism mediated by the 5Ј-end of the coding region of NIPP-1 mRNA (14) . We report here the successful expression of NIPP-1 in Sf 9 cells using the baculovirus expression system. The inhibitory properties of the purified recombinant protein are described as well as the identity and the probable function of the PKA and CK2 phosphorylation sites.
EXPERIMENTAL PROCEDURES
Materials, Western or Far Western Analysis, Assays, and Statistics-PP-1 C (15), protein phosphatase-2A C (16) , and phosphorylase b (17) were purified from rabbit skeletal muscle. The catalytic subunit of PKA from beef heart, histone 2A, and myelin basic protein were purchased from Sigma. Histone H1 and the digoxygenin protein labeling and detection kit were obtained from Boehringer. Protein kinase CK2 was isolated from pig spleen (18) . One unit of PKA or CK2 introduces 1 nmol of phosphate/min into casein at 30°C. Casein was prepared according to the procedure of Mercier et al. (19) . A kit for the development of Western blots by enhanced chemiluminescence was purchased from Amersham Corp. Digoxygenin-labeled PP-1 C was prepared as detailed in Ref. 4 .
Far Western blotting with digoxygenin-labeled PP-1 C and Western analysis with antibodies against either the C-terminal 11 residues of NIPP-1 or the C-terminal 10 residues of PP-1 C␦ were done according to Jagiello et al. (4) . Phosphorylase b was phosphorylated in the presence of [␥-32 P]ATP by purified phosphorylase kinase (20) . Casein, myelin basic protein, and histone IIA were phosphorylated by PKA (9) , and histone H1 was phosphorylated by p34 cdc2 (21) . The basal ("spontaneous") and trypsin-revealed ("total") protein phosphatase activities were determined as described previously (9) . The assay buffer contained 50 mM glycylglycine at pH 7.4, 0.5 mM dithiothreitol, and 5 mM ␤-mercaptoethanol (buffer A). One unit of phosphatase releases 1 nmol of phosphate/min at 30°C. NIPP-1 was assayed as an inhibitor of PP-1 C (9) using the indicated 32 P-labeled substrates. Statistics are given as the means Ϯ S.E. for the indicated number (n) of experiments.
Baculovirus Expression of NIPP-1-The NIPP-1 cDNA from bovine thymus was excised from the bacterial expression vector pBl-2175 (10) as a XbaI-KpnI fragment and cloned into the baculovirus transfer vector pVL1392 under control of the polyhedrin promotor (Invitrogen). Recombinant viruses expressing NIPP-1 were generated through intracellular homologous recombination (22) .
For the production of recombinant NIPP-1, Sf 9 cells were grown as monolayer cultures at 27°C in TC 100 medium (Life Technologies, Inc.) supplemented with 10% (v/v) heat-inactivated fetal bovine serum. The cells were infected with the recombinant virus at a multiplicity of infection of 10 and harvested by centrifugation (5 min at 1,000 ϫ g) after 62-72 h, when the expression of NIPP-1 was maximal (see Fig. 1 ).
Purification of Recombinant NIPP-1-The infected Sf 9 cells from four 14-cm Petri dishes (ϳ8 ϫ 10 7 cells) were washed once with phosphate-buffered saline at pH 7.4 (1.8 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 , 150 mM NaCl) and resuspended in lysis buffer consisting of 50 mM Tris/HCl at pH 8.0, 150 mM NaCl, 0.5% (v/v) Triton X-100, 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM benzamidine, and 5 M leupeptin. The lysate was cleared by centrifugation (5 min at 1,000 ϫ g), and the supernatant (about 50 ml) was mixed with 20 ml of heparin-Sepharose (Pharmacia Biotech Inc.), equilibrated in 20 mM Tris/HCl at pH 6.8, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM benzamidine, and 5 M leupeptin (buffer B) plus 150 mM NaCl. After an incubation for 1 h at 4°C on a rotating wheel, the gel was first washed with five volumes of buffer B plus 150 mM NaCl. Subsequently, the retained proteins, including NIPP-1, were eluted with buffer B plus 400 mM NaCl. The eluate was concentrated until 2 ml in a Vivaspin ultracentrifugation unit (VivaScience). After a 10-fold dilution with buffer C containing 20 mM Tris/HCl at pH 7.4, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM benzamidine, and 5 M leupeptin, the sample was applied to an anion exchange column (Poros HQ column from PerSeptive Biosystems), equilibrated in buffer C plus 50 mM NaCl. The bound proteins were eluted with 40 ml of a linear salt gradient (50 -300 mM NaCl) in buffer C. The fractions that contained NIPP-1 activity were pooled, dialyzed overnight against buffer C plus 60% (v/v) glycerol, and stored at Ϫ20°C.
Phosphorylations and Phosphopeptide Mapping-All phosphorylations were done for the indicated time at 30°C in buffer A, supplemented with 0.1 mM ATP (with or without [␥-32 P]ATP), 2 mM magnesium acetate, and PKA (42 milliunits/ml), and/or CK2 (525 milliunits/ ml). For phosphopeptide and phosphoamino acid analysis, 50 g of NIPP-1 was radioactively phosphorylated for 90 min in a final volume of 300 l. The reaction was stopped by the addition of 20% (w/v) trichloroacetic acid. The washed and air-dried pellet was resuspended in 45 l of digestion buffer containing 100 mM Tris/HCl at pH 8.5, 0.01% SDS, and 5 g of trypsin of sequencing grade (Boehringer). After an incubation for 16 h at 37°C, the resulting peptide mixture was applied to a RPC C2/C18 SC 2.1/10 reversed-phase column, equilibrated in 10 mM ammonium acetate at pH 6.5. The retained peptides were eluted with a linear gradient (0 -70%) of acetonitrile in 10 mM ammonium acetate (pH 6.5) over a period of 90 min at a flow rate of 80 l/min. The eluted peptides, as detected by absorbance measurements at 215 nm, were collected manually and counted for Cerenkov radiation. This resulted in the identification of four radioactive peaks, termed peaks A, B, C, and D in , were subjected to hydrolysis in 6 M HCl for 90 min at 110°C. The digest was supplemented with phosphoamino acid standards and analyzed by thin layer electrophoresis at pH 1.9 (23). The radioactively labeled residues were localized by autoradiography and identified by comparison with the migration of phosphoamino acid standards visualized with ninhydrin. Peptides A, B, C, and D were sequenced with an Applied Biosystems Procise model 492 protein sequencer in the pulsed liquid mode. The repetitive yield of the sequencer was 94.5%. The molecular mass of purified recombinant NIPP-1 was determined by ion spray mass spectrometry (Perkin-Elmer Sciex API-300) in the presence of 50% (v/v) acetic acid to increase the protein solubility and ionization. The analysis was done in a single quadrupole operating mode using quadrupole 3 of the mass analyzer.
RESULTS

Expression and Characterization of Intact NIPP-1-Infection
of Sf 9 cells with the recombinant baculovirus resulted after 48 -72 h in the generation of a polypeptide with the mass of NIPP-1 (47 kDa on 10% Tricine-SDS-PAGE) as detected by Coomassie staining of cell lysates (Fig. 1 ). The identity with NIPP-1 was confirmed by Western blotting with antibodies against the C terminus of NIPP-1 and by Far Western analysis with digoxygenin-labeled PP-1 C . The recombinant NIPP-1 was purified until homogeneity by consecutive chromatographies on heparin-Sepharose and Poros HQ (Fig. 1) . Using this procedure, 8.0 Ϯ 0.3 g (n ϭ 3) of NIPP-1 could be purified from 10 6 cells with an overall recovery of 22 Ϯ 5%.
Purified recombinant NIPP-1 did not affect the activity of the catalytic subunit of protein phosphatase-2A (not shown), but completely inhibited PP-1 C using as substrates phosphorylase, myelin basic protein, histone H1, histone 2A, or casein (not shown). Over a wide range of PP-1 C concentrations, NIPP-1 was inhibitory at stoichiometric levels (not shown). The apparent K i value, calculated by extrapolation of the IC 50 to infinite dilutions of the phosphatase (24) , amounted to 9.9 Ϯ 3.3 pM (n ϭ 3).
Phosphorylation of NIPP-1-Recombinant NIPP-1 was an excellent substrate for phosphorylation by PKA and CK2 ( Fig.  2A) . The stoichiometries of phosphorylation amounted to 1.9 Ϯ 0.2, 1.1 Ϯ 0.1, and 2.9 Ϯ 0.3 mol of phosphate/mol NIPP-1 (n ϭ 4) for phosphorylation by PKA, CK2, and PKA ϩ CK2, respectively. Phosphorylation of NIPP-1 by PKA or CK2 reduced the FIG. 1. Generation and purification of baculovirus-expressed NIPP-1. Sf 9 cells were infected with the wild type (WT) or with recombinant baculovirus (see "Experimental Procedures"). At the indicated times (72 h for the wild type), cell lysates were subjected in triplicate to 10% Tricine-SDS-PAGE. One gel was stained with Coomassie Blue. The two other gels were blotted onto polyvinylidene difluoride membranes, and NIPP-1 was visualized on the blots either by Western analysis or by a Far Western overlay with digoxygenin-labeled PP-1 C . The arrow points to the expected migration of NIPP-1 (47 kDa). The major bands of 10 and 29 kDa in the wild type lysate represent p10 and polyhedrin, respectively, which are both encoded by the viral genome. p10 is also visible 72 h after infection with the recombinant virus. The right panel shows a Coomassie staining of NIPP-1 at various stages of the purification.
amount of digoxygenin-labeled PP-1 C that was bound during Far Western blotting (Fig. 2B) . Virtually no binding of PP-1 C was detected any more after phosphorylation of NIPP-1 with both kinases. Phosphorylation by PKA or CK2 also increased the concentration of NIPP-1 that was required for the halfmaximal inhibition of PP-1 C , and the effect of both kinases was additive (Fig. 2C) . NIPP-1 that had been phosphorylated by PKA ϩ CK2 was completely inefficient in inhibiting a stoichiometric concentration of PP-1 C (0.5 nM in Fig. 2C) .
Remarkably, the inactivation of NIPP-1 by phosphorylation was only detected at physiological salt concentrations (Fig. 3) . The same results were obtained with 150 mM of NaCl (Fig. 3) , or KCl, NaHCO 3 , or still CH 3 COONa (not shown) in the assay, showing that the effect was due to the ionic strength rather than to the type of salt. On the other hand, the extent of phosphorylation of NIPP-1 by PKA and CK2 was not affected by the presence of 150 mM salt (not shown).
Because NIPP-1 is associated with PP-1 C in mammalian nuclei (see the Introduction), it remained important to determine whether the observed regulation of NIPP-1 by PKA and CK2 could also be demonstrated with the holoenzyme PP-1N NIPP-1 . For that purpose an in vitro reconstituted heterodimeric complex between PP-1 C and NIPP-1 was prepared by mixing equimolar amounts of both components. The spontaneous phosphorylase phosphatase activity of the resulting complex (5 Ϯ 1 milliunits/ml; n ϭ 4), as measured in the presence of 0.15 M NaCl, increased to 23 Ϯ 1 and 72 Ϯ 3 milliunits/ml after phosphorylation by CK2 or PKA, respectively. An even larger activation was obtained by phosphorylation with both PKA and CK2 (130 Ϯ 5 milliunits/ml). Following proteolysis of the complex with trypsin, resulting in the release of a fully active, C-terminally nicked PP-1 C (2), the phosphorylase phosphatase activity amounted to 593 Ϯ 12 milliunits/ml.
We have also investigated whether the activation of PP-1N NIPP-1 by PKA and CK2 affected the holo-enzyme structure. In Fig. 4 it is shown that PP-1N NIPP-1 migrated as a protein of 120 kDa during gel filtration on Superdex-200. The holoenzyme was completely inactive, but an activity could be revealed by prior trypsinolysis of NIPP-1 in the column fractions (Fig. 4) . After phosphorylation by PKA plus CK2, PP-1N NIPP-1 was spontaneously active but migrated identically to the nonphosphorylated holoenzyme. The co-migration of NIPP-1 and PP-1 C was confirmed by Western analysis (inset of Fig. 4) . These data show that the activation of PP-1N NIPP-1 by PKA plus CK2 was not associated with a release of NIPP-1. In agreement with this conclusion, we found that incubation of the nuclear particulate fraction (prepared as described in Ref. 4 ) with PKA and CK2 under phosphorylating conditions did not result in the release of NIPP-1 or PP-1 C , as detected by Western blotting and activity assays of the resedimented particulate fraction, respectively (not shown).
Identification of the Phosphorylation Sites-After phosphorylation of purified recombinant NIPP-1 by PKA and/or CK2 in the presence of [␥-32 P]ATP, the inhibitor was fragmented by trypsinolysis. The tryptic digest was fractionated by reversedphase chromatography on a C2/C18 column (see "Experimental Procedures"). Two major peaks of radioactivity (peaks A and B in Fig. 5) were detected in the eluate after phosphorylation of NIPP-1 by PKA (see above). Likewise, two radioactive peaks (pools C and D in Fig. 5) were identified in the tryptic digest of CK2-phosphorylated NIPP-1, which eluted, however, differently from the phosphopeptides derived from PKA-phosphorylated NIPP-1. One of the peaks obtained from CK2-phosphorylated NIPP-1 was reproducibly less radioactive, suggesting a substoichiometric phosphorylation, in agreement with the lower stoichiometry of phosphorylation of NIPP-1 by CK2 as compared with that by PKA. After phosphorylation of NIPP-1 with both PKA and CK2, four radioactive peaks were obtained that eluted identically to peaks A, B, C, and D (Fig. 5, lower   FIG. 3 . The inhibitory potency of phospho-NIPP-1 is dependent on the ionic strength. NIPP-1 was incubated for 90 min at 30°C in the absence (Control) or the presence of PKA ϩ CK2 under phosphorylating conditions, as indicated under "Experimental Procedures." After the arrest of the phosphorylation reaction with 5 mM EDTA, NIPP-1 was assayed as an inhibitor of PP-1 C (0.5 nM), using phosphorylase a as a substrate, in the absence or the presence of 150 mM NaCl. The results represent the means Ϯ S.E. for three experiments. B shows an overlay with digoxygenin-labeled PP-1 C after 10% Tricine-SDS-PAGE and blotting on polyvinylidene fluoride membranes. In C, the effects of phosphorylation of NIPP-1 on its inhibition of 0.5 nM PP-1 C are shown, using phosphorylase a as a substrate, in an assay mixture containing 0.15 M NaCl. The results in C are expressed as a percentage of the phosphatase activity in the absence of NIPP-1 and represent the means Ϯ S.E. for three experiments.
panel). The same four peaks were obtained after phosphorylation of NIPP-1 in a heterodimeric complex with PP-1 C (not shown).
The radioactive peptides corresponding to peaks A-D could be sequenced, following an additional purification step by reversed-phase chromatography (see "Experimental Procedures"). All four phosphopeptides ended with an Arg or Lys (Table I) , as expected from the cleaving specificity of trypsin. Likewise, by comparison with the known primary structure of NIPP-1 (10), it was confirmed that all peptides were preceded by an Arg or Lys residue (not illustrated). Peptides A, B, and C were exclusively phosphorylated on Ser, whereas peptide D was exclusively phosphorylated on Thr (Table I) (Table I) . In contrast, all other Ser and Thr residues in the same peptides showed a recovery of Ն86% of the expected value (not shown). The reduced recovery of some Ser/Thr residues could not be explained by their covalent modification during the expression of NIPP-1 in Sf 9 cells. Indeed, the mass of purified recombinant NIPP-1 was established by mass spectrometry as 38,520 Da (not illustrated), which is exactly the mass calculated from its known primary structure (10) Sequence and phosphoamino acid analyses showed that the phosphopeptides derived from NIPP-1 that had been phosphorylated by both PKA and CK2 were identical and phosphorylated on the same residues as those obtained after phosphorylation with the individual kinases (not illustrated).
Phosphorylation of Synthetic Peptides-Based upon the presence of consensus sequences, NIPP-1 was predicted to contain three phosphorylation sites for PKA, whereas only two of these sites were identified as real phosphorylation sites. Similarly, we only detected two phosphorylation sites for CK2, whereas NIPP-1 contains four additional consensus sequences for phosphorylation by CK2. We have used synthetic peptides to further analyze the substrate quality of two sites that were predicted to be phosphorylated by PKA or CK2 but were not recovered as phosphorylation sites in intact NIPP-1. Thus, Thr 346 was predicted to be a PKA phosphorylation site. However, a synthetic peptide (PGKKPTPSLLI) comprising the C terminus (residues 341-351) of NIPP-1 was only phosphorylated marginally (Ͻ0.01 mol/mol) by PKA. Furthermore, phosphoamino acid analysis showed that the label was exclusively associated with phosphoserine, confirming that Thr 346 is not a PKA phosphorylation site (not shown). On the other hand, a peptide (RPKRKRKNSRVTFSEDDEII) comprising residues 191-210 of NIPP-1 and containing the Ser 199 and Ser 204 phosphorylation sites for PKA and CK2, respectively, was phosphorylated by both kinases albeit not to stoichiometric levels (Fig.  6 ). The stoichiometry of phosphorylation of p191-210 by PKA plus CK2 was additive. Interestingly, PKA phosphorylated this peptide much faster than did CK2, despite the 10-fold higher concentration of the latter kinase. A similar superior substrate quality for phosphorylation by PKA has previously also been described for the purified 16/18-kDa NIPP-1 fragments (11) . Phosphoamino acid analysis demonstrated that p191-210 was exclusively phosphorylated on Ser by PKA and/or CK2 (not shown), providing additional evidence that Thr 202 , albeit a predicted CK2 phosphorylation site, was in reality not phosphorylated at all by this kinase.
DISCUSSION
The Properties of Recombinant NIPP-1-Baculovirus-expressed NIPP-1 (this work) and the heat stable NIPP-1a/b fragments (9) turned out to be equally potent inhibitors of PP-1 C . Both the intact protein (Figs. 2-4 ) and NIPP-1a/b (11, 12) were also inactivated by phosphorylation with PKA and CK2. Collectively, these data suggest that the N-and C-terminal thirds of NIPP-1 are not directly involved in the inhibitory interaction with PP-1 C . On the other hand, the heterodimeric complex of PP-1 C and NIPP-1 was not dissociated by activation with PKA and CK2 (Fig. 4) , although the complex with NIPP1a/b was dissociated (11, 12) and phosphorylation of intact NIPP-1 obviously decreases its affinity for the catalytic subunit (Fig. 2) . This suggests that the N-and/or C-terminal thirds of NIPP-1 contain at least one additional binding site for the catalytic subunit (Fig. 7) . Our finding that PP-1N NIPP-1 is not dissociated by activation also provides further evidence that NIPP-1 is a real subunit of PP-1 rather than a transiently associated regulator.
In contrast to what has been reported for NIPP-1a/b (11, 12) , the PKA-and CK2-mediated inactivation of intact NIPP-1 was only expressed at physiological ionic strength. This requirement for salt explains our previous failure to detect an activation of PP-1N NIPP-1 in nuclear extracts by phosphorylation with PKA or CK2 (4). Interestingly, the effects of some other regulators of PP-1 are also salt-dependent. Thus, the allosteric inhibition of the glycogen-synthase phosphatase activity of hepatic glycogen-bound PP-1 by phosphorylase a (2) and the stimulation of this activity by glucose 6-phosphate (29) require salt. In contrast, the time-dependent inactivation of PP-1 C by inhibitor-2 is blocked by physiological salt concentrations (30) .
Phosphorylation Sites of NIPP-1-Thr 161 and Ser 204 of NIPP-1 were identified as the CK2 phosphorylation sites (Table I). Both sites were predicted to be CK2 phosphorylation sites (10), because they are followed by an acidic residue at position ϩ3, which is the most essential determinant for recognition by CK2 (31, 32) . Similarly, the two PKA phosphorylation sites in NIPP-1 (Ser 178 and Ser 199 ) are canonical recog- 
-derived phosphopeptides and the identity of the phosphorylated residues
The primary structure of the phosphopeptides corresponding to peaks A, B, C, and D in Fig. 6 was determined following an additional purification step of each peptide (see "Experimental Procedures"). The residues with a reduced yield are shown in parentheses. Because of the severely reduced yield, Ser 178 and Ser 204 could only be identified by comparison of the peptide sequence with the known structure of NIPP-1. The yield of the phosphorylated residues is expressed as a percentage of the expected value. The expected yield was 47 Ϯ 1 and 70 Ϯ 2% (n ϭ 12) for Ser and Thr, respectively, and was an average of the recoveries of these residues in control sequences derived from lactoglobulin and the PR65 subunit of protein phosphatase-2A. The yield of the nonphosphorylated Ser and Thr residues in peptides A-D was Ն86%. An aliquot of each peptide was also processed for phosphoamino acid analysis. The same phosphopeptides and phosphorylated residues were obtained after phosphorylation of NIPP-1 by PKA plus CK2 (not shown). nition sites for PKA, because they are preceded at positions Ϫ2 and Ϫ3 by basic residues. Although it remains to be investigated whether all these sites are phosphorylated in vivo, it should be pointed out that the glucagon-induced activation of PKA has previously been associated with a phosphorylation of NIPP-1 in rat liver in vivo (4) .
Some predicted phosphorylation sites for PKA and CK2 (10) were not identified as real phosphorylation sites in intact NIPP-1. This is particularly striking for Thr 202 , which has four downstream acidic residues (positions ϩ3 to ϩ6) and was expected to become an even better recognition site for CK2 after prior phosphorylation of Ser 204 (31, 32) . It seems unlikely that the absence of phosphorylation of Thr 202 is explained by an inaccessibility due to conformational restraints because this residue was not phosphorylated either when present in a small synthetic peptide (see "Results"). A similar mystery is the absence of phosphorylation of Thr 346 by PKA. We have found that intact NIPP-1 is exclusively phosphorylated by PKA on Ser, whereas the NIPP-1a/b fragments were reported to be phosphorylated also on Thr (11) . The reason for this discrepancy is not clear. Although it cannot be ruled out that NIPP-1a/b contains PKA phosphorylation sites that are not accessible in intact NIPP-1, there are no canonical Thr phosphorylation sites for PKA in the central third of NIPP-1, which roughly corresponds to NIPP-1a/b (10). It is more probable that the previously observed phosphorylation on Thr stemmed from a contaminant of the NIPP-1a/b preparation.
Recently, Egloff et al. (33) demonstrated that most known regulators of PP-1, including NIPP-1, contain an RVXF motif that mediates the binding to PP-1 C . Interestingly, residue X in the RVXF motif of the glycogen-binding G-subunit of PP-1 corresponds to a Ser that can be phosphorylated by PKA, resulting in the dissociation of the G-subunit from PP-1 C . Residue X of the RVXF motif in NIPP-1 corresponds to Thr 202 , which is a consensus phosphorylation site for CK2 but is not phosphorylated by CK2 (see above). However, the RVXF motif in NIPP-1 is N-terminally and C-terminally bordered by phosphorylation sites for PKA (Ser 199 ) and CK2 (Ser 204 ), respectively. We speculate that the phosphorylation of the latter sites causes a dissociation of the RVXF motif from PP-1 C , resulting in an activation of PP-1N NIPP-1 . Egloff et al. (33) reported that a synthetic peptide comprising the RVXF motif of p53BP2 interfered with the interaction between PP-1 C and the glycogen-binding or myosin-binding subunits (33) . We found, however, that PP-1N NIPP-1 could not be activated by the addition of a large excess of p191-210 containing the RVXF motif of NIPP-1.
2 This is consistent with the presence of a second site of interaction between NIPP-1 and PP-1 C (Fig. 7) .
